Please login to the form below

Future focus: 3 tools for launching fast in the face of uncertainty

Dan Twibell, Head of Commercial Strategy, Consulting at Fishawack Health, reveals 3 fundamental tools for lean biotechs approaching a rapid launch. He gives his advice on how to manage resources effectively and ensure the strategy remains agile in a changing market landscape.

Imagine you had a crystal ball which allowed you to see into the future and understand exactly how your life science launch would pan out. You could see the barriers that would impact your clinical trials, the siloes slowing down decision making, and even look far into the horizon to understand how your product launch would impact the entire portfolio.

While no one has access to a magical fortune-telling device, some tools can help you plan for the many uncertainties that could influence your launch. Numerous factors can slow down a product launch, and these barriers only become more challenging in an accelerated and rapid timeline. Tools like scenario planning, the target product profile, and a commercialization blueprint can help you develop a battle-ready strategy that focuses the organization on critical launch objectives and sustainable benefits of the product.

Fishawack Health interviews Dan Twibell, Head of Commercial Strategy in our consulting team, to explore how biotechnology companies can remain agile when navigating the path to an accelerated or fast-track launch without overstretching limited resources.

Have you noticed a trend in launches becoming faster and more complex during the past couple of years?

Absolutely, there is an emerging theme of “hurry up and wait.” Life science companies hoping for an accelerated launch need to prepare for an aggressive timeline. However, they are also aware that the regulatory body may not grant them accelerated or fast-track approval, and they could be working at a much slower pace. So, we’re seeing clients who are planning for two parallel paths to launch–one where they need to hurry up and move at lightning speed and one where they need to wait and take a slower, more measured approach.

DOWNLOAD THE FULL ARTICLE HERE

12th October 2021

Share

Tags

Company Details

Fishawack Health

+44 20 3328 1840

Contact Website

Address:
No. 3 Booths Park
Booths Hall
Chelford Road
Knutsford
Cheshire
WA16 8GS
United Kingdom

Latest content on this profile

Future focus: 3 tools for launching fast in the face of uncertainty
Dan Twibell, Head of Commercial Strategy, Consulting at Fishawack Health, reveals 3 fundamental tools for lean biotechs approaching a rapid launch. He gives his advice on how to manage resources effectively and ensure the strategy remains agile in a changing market landscape.
Fishawack Health
Fishawack Health appoints new CEO, Jonathan Koch
Koch will draw on his exceptional experience leading global, customer-centered organizations of scale to build a sustainable future for Fishawack Health.
Fishawack Health
Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
Elizabeth Landon brings exceptional leadership from a career supporting and scaling people-based businesses in the professional services and non-profit sectors.
Fishawack Health
Hepatitis (C)an’t wait: taking a de-centralized approach to cure the epidemic
Hepatitis C is a curable disease, so why are so many countries off track to achieve the World Health Organization elimination target? This World Hepatitis Day, we compare several countries’ approaches to combatting the disease and explore the importance of a de-centralized strategy that overcomes the stigma preventing patients from seeking treatment.
Fishawack Health
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals how life science companies can cut through the noise to drive uptake of innovative therapies, including novel TYK2 inhibitors.
Fishawack Health
Healthcare tech: the driving force behind value-based care?
In 2020, healthcare technology investment went into overdrive. We speak to Sunny Kumar, Partner at GSR Ventures, to find out how COVID‑19 has transformed the industry and whether healthcare technology can bring us one step closer to a value-based model of care.
Fishawack Health